Literature DB >> 28881876

Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.

Hai Yun Shi1,2, Francis K L Chan2, Anthony W H Chan3, Akira Higashimori2, Moe Kyaw2, Jessica Y L Ching2, Arthur K C Luk2, Sunny H Wong2, Justin C Y Wu2, Joseph J Y Sung2, Siew C Ng2.   

Abstract

BACKGROUND AND AIMS: Endoscopic and histological healing are associated with improved clinical outcomes in ulcerative colitis [UC]. We aimed to investigate the predictive value of faecal immunochemical test [FIT] for endoscopic and histological healing in UC.
METHODS: We measured quantitative FIT and faecal calprotectin [FC] in 140 consecutive UC patients who underwent colonoscopy. We assessed the diagnostic accuracy of FIT for predicting endoscopic healing using the Mayo endoscopic subscore [MES 0/1] and for histological healing using the Geboes score [< 2.0] and Nancy index [grade ≤ 1]. The predictive abilities of FIT were compared with those of FC.
RESULTS: FIT had an area under the curve [AUC] of 0.77 (95% confidence interval [CI] 0.67-0.86, p < 0.001) for endoscopic healing, an AUC of 0.77 [95% CI 0.67-0.86, p < 0.001] using the Geboes score, and 0.77 [95% CI 0.66-0.85, p < 0.001] using the Nancy Index for histological healing. The AUC of FIT was comparable to that of FC for endoscopic healing [p = 0.773] and histological healing [p = 0.767-0.960], and was comparable to colonoscopy for histological healing [p = 0.384-0.673]. FIT < 50 ng/ml predicted endoscopic healing with a sensitivity, specificity, and positive predictive value [PPV] of 72%, 68%, and 82%, respectively, and for histological healing with a sensitivity, specificity, and PPV of 73-75%, 67%, and 78-80%, respectively. Combining FIT with FC led to a higher specificity [90%] for histological healing. Over 85% of patients with FIT < 50 ng/ml and FC < 50 μg/g achieved histological healing.
CONCLUSIONS: FIT is highly sensitive and accurate to predict endoscopic and histological healing in UC. It represents a promising non-invasive tool for monitoring mucosal healing in UC.
Copyright © 2017 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Ulcerative colitis; faecal immunochemical test; mucosal healing

Mesh:

Substances:

Year:  2017        PMID: 28881876     DOI: 10.1093/ecco-jcc/jjx088

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  9 in total

1.  Paediatric Ulcerative Colitis Is a Fibrotic Disease and Is Linked with Chronicity of Inflammation.

Authors:  Ilyssa O Gordon; Suha Abushamma; Jacob A Kurowski; Stefan D Holubar; Lei Kou; Ruishen Lyu; Florian Rieder
Journal:  J Crohns Colitis       Date:  2022-06-24       Impact factor: 10.020

2.  Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis.

Authors:  Hsu-Heng Yen; Mei-Wen Chen; Yu-Yao Chang; Hsuan-Yuan Huang; Tsui-Chun Hsu; Yang-Yuan Chen
Journal:  PeerJ       Date:  2020-07-14       Impact factor: 2.984

3.  Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.

Authors:  I O Gordon; N Agrawal; E Willis; J R Goldblum; R Lopez; D Allende; X Liu; D Y Patil; L Yerian; F El-Khider; C Fiocchi; F Rieder
Journal:  Aliment Pharmacol Ther       Date:  2018-02-06       Impact factor: 8.171

4.  Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission.

Authors:  Natsuki Ishida; Kiichi Sugiura; Takahiro Miyazu; Satoshi Tamura; Satoshi Suzuki; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Clin Transl Gastroenterol       Date:  2020-12       Impact factor: 4.396

5.  Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis.

Authors:  Xiaoqi Ye; Ying Wang; Harry H X Wang; Rui Feng; Ziyin Ye; Jing Han; Li Li; Zhirong Zeng; Minhu Chen; Shenghong Zhang
Journal:  Therap Adv Gastroenterol       Date:  2021-02-27       Impact factor: 4.409

Review 6.  Fecal biomarkers: Non-invasive diagnosis of colorectal cancer.

Authors:  Qian Ding; Xiangxu Kong; Weilong Zhong; Wentian Liu
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

7.  C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.

Authors:  Natsuki Ishida; Tomohiro Higuchi; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

8.  Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients.

Authors:  Mark S Johnstone; Gillian Miller; Grace Pang; Paul Burton; Georgios Kourounis; Jack Winter; Emilia Crighton; David Mansouri; Paul Witherspoon; Karen Smith; Stephen T McSorley
Journal:  Ann Clin Biochem       Date:  2022-03-03       Impact factor: 2.587

Review 9.  Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease.

Authors:  Kohei Wagatsuma; Yoshihiro Yokoyama; Hiroshi Nakase
Journal:  Life (Basel)       Date:  2021-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.